Literature DB >> 4588090

Effects of antacids on gastrointestinal absorption of isoniazid in rat and man.

A Hurwitz, D L Schlozman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4588090     DOI: 10.1164/arrd.1974.109.1.41

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  14 in total

1.  Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  [Interactions between nutrition and drugs].

Authors:  G Czok
Journal:  Z Ernahrungswiss       Date:  1976-06

Review 3.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 4.  Antacid therapy and drug kinetics.

Authors:  A Hurwitz
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

5.  Effect of antacids in didanosine tablet on bioavailability of isoniazid.

Authors:  K Gallicano; J Sahai; G Zaror-Behrens; A Pakuts
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 6.  Influence of food on the bioavailability of drugs.

Authors:  A Melander
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 7.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 8.  Adverse antibiotic drug interactions.

Authors:  A J Bint; I Burtt
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

Review 9.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

10.  The effects of omeprazole-induced hypochlorhydria on absorption of theophylline from a sustained-release formulation.

Authors:  D K Sommers; M van Wyk; J R Snyman; J Moncrieff
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.